UA101988C2 - ANTIBODIES AGAINST HUMAN TRANSFORMING GROWTH FACTOR BETA RECEPTOR II (TGFβRII) - Google Patents

ANTIBODIES AGAINST HUMAN TRANSFORMING GROWTH FACTOR BETA RECEPTOR II (TGFβRII)

Info

Publication number
UA101988C2
UA101988C2 UAA201105368A UAA201105368A UA101988C2 UA 101988 C2 UA101988 C2 UA 101988C2 UA A201105368 A UAA201105368 A UA A201105368A UA A201105368 A UAA201105368 A UA A201105368A UA 101988 C2 UA101988 C2 UA 101988C2
Authority
UA
Ukraine
Prior art keywords
growth factor
transforming growth
against human
antibodies against
factor beta
Prior art date
Application number
UAA201105368A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Янь Ву
Original Assignee
Имклоун Ллк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Имклоун Ллк filed Critical Имклоун Ллк
Priority claimed from PCT/US2009/062450 external-priority patent/WO2010053814A1/en
Publication of UA101988C2 publication Critical patent/UA101988C2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention is directed to antibodies against human transforming growth factor beta receptor II (TGFβSRII), pharmaceutical compositions comprising antibodies and methods of using the antibodies, alone or in combination, for example, for treating cancer and fibrosis.
UAA201105368A 2008-11-07 2009-10-29 ANTIBODIES AGAINST HUMAN TRANSFORMING GROWTH FACTOR BETA RECEPTOR II (TGFβRII) UA101988C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19869708P 2008-11-07 2008-11-07
PCT/US2009/062450 WO2010053814A1 (en) 2008-11-07 2009-10-29 Anti-tgf-beta receptor ii antibodies

Publications (1)

Publication Number Publication Date
UA101988C2 true UA101988C2 (en) 2013-05-27

Family

ID=51949539

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201105368A UA101988C2 (en) 2008-11-07 2009-10-29 ANTIBODIES AGAINST HUMAN TRANSFORMING GROWTH FACTOR BETA RECEPTOR II (TGFβRII)

Country Status (1)

Country Link
UA (1) UA101988C2 (en)

Similar Documents

Publication Publication Date Title
EA201170659A1 (en) ANTIBODIES TO TGF-VETA RECEPTOR II
IN2012DN01920A (en)
MX2019009654A (en) Folate receptor 1 antibodies and immunoconjugates and uses thereof.
TN2011000463A1 (en) Composition and methods for increasing muscle growth
TN2012000040A1 (en) High affinity human antibodies to human angiopoietin -2
MX2009009592A (en) Aminopyridines useful as inhibitors of protein kinases.
MX2011010908A (en) Anti-tnf-î± antibodies and their uses.
IN2012DN02081A (en)
MX2009008510A (en) Activin-actriia antagonists and uses for promoting bone growth in cancer patients.
HK1138572A1 (en) Aminopyrimidines useful as inhibitors of protein kinases
MX2011007930A (en) Crystalline insulin-conjugates.
TW200716646A (en) (S)-N-methylnaltrexone
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
MX2009009079A (en) Engineered anti-il-23p19 antibodies.
MX2009009080A (en) Engineered anti-il-23p19 antibodies.
WO2010048026A3 (en) Fibroblast growth factor receptor-3 (fgfr-3) inhibitors and methods of treatment
MX370721B (en) Novel compounds and compositions for targeting cancer stem cells.
MX2012006430A (en) Combination preparations comprising a cytokine antagonist and corticosteroid.
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
MX2011014019A (en) Diazahomoadamantane derivatives and methods of use thereof.
MX2010009743A (en) Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members.
MX342947B (en) Treatment of type 2 diabetes.
WO2011116212A3 (en) Bone morphogenetic protein receptor binding agents and methods of their use
MY164998A (en) Isoquinolinone derivatives as nk3 antagonists
EP2597949A4 (en) Sub-micron compositions